United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 5, 2026 · Filed Jun 8, 2026

On Jun 5, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$547.62 for US$5.2M under a trading plan, leaving 40,513 shares. Filed Jun 8, 2026 (Form 4).

Sold
9,500 shares
Price
US$547.62 average (US$545.99 to US$550.53)
Value
US$5.2M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 5, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 5, 2026Common StockSale1,737US$545.9948,276Direct
Jun 5, 2026Common StockSale2,808US$546.8845,468Direct
Jun 5, 2026Common StockSale2,366US$547.8543,102Direct
Jun 5, 2026Common StockSale1,289US$548.8141,813Direct
Jun 5, 2026Common StockSale1,202US$549.7740,611Direct
Jun 5, 2026Common StockSale98US$550.5340,513Direct

Source

View original at SEC

Related